Position history for BlackRock, Inc.'s holdings in BRIDGEBIO PHARMA INC
BlackRock, Inc. holds 14.2M shares of BBIO (BRIDGEBIO PHARMA INC), worth $1.1B as of 2026-Q1. The position was decreased (-2.4% shares). BBIO represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$1.1B
Current Shares
14.2M
Total Value Change
+$678.9M
Total Shares Change
+498,111
Other major holders of BBIO: VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC
Decreased |
| 14.2M |
-2.4% |
| $1.1B |
| 0.0% |
| $64.53 |
0 |
| 2025-Q4 | Increased | 14.5M | +1.0% | $1.1B | 0.0% | $75.48 | 32 |
| 2025-Q3 | Increased | 14.4M | +1.1% | $748.5M | 0.0% | $51.96 | 32 |
| 2025-Q2 | Increased | 14.3M | +6.8% | $615.7M | 0.0% | $44.86 | 34 |
| 2025-Q1 | Decreased | 13.4M | -2.6% | $461.8M | 0.0% | $35.11 | 0 |
| 2024-Q4 | New | 13.7M | - | $376.2M | 0.0% | $27.32 | 43 |